Using pharmacoeconomic analysis to make drug insurance coverage decisions

PharmacoEconomics

Volumn 13, Issue 1 PART II, 1998, Pages 119-126

  Anis, Aslam H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ARTICLE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DECISION MAKING; DRUG APPROVAL; DRUG COST; INSURANCE; PHARMACOECONOMICS; PRIORITY JOURNAL; REIMBURSEMENT;

BRITISH COLUMBIA; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; FORMULARIES; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT;

EID: 0031973369     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199813010-00011     Document Type: Article

References (2)

1. Canadian Ministry of Supply and Services. National drug expenditures in Canada, 1975-1994, Ottawa: Ministry of Supply and Services, 1996. Cat H21-99/1994, ISBN 0-662-62169-7
2. Anis A. Substitution laws, insurance coverage, and generic drug use. Med Care 1994; 32: 240-56